Allegiance Bioscience is an emerging biopharmaceutical company. Backed by a healthcare and pharmaceutical private equity firm. Allegiance focuses on the acquisition and commercialization of specialty and generic pharmaceutical products.Allegiance seeks to acquire mature, patented, and generic prescr…
Allegiance Bioscience is an emerging biopharmaceutical company. Backed by a healthcare and pharmaceutical private equity firm. Allegiance focuses on the acquisition and commercialization of specialty and generic pharmaceutical products.
Allegiance seeks to acquire mature, patented, and generic prescription pharmaceutical products and to grow their value using several strategies including:
Reinvigorated promotional activity
Improved product supply chain
Rational pricing strategies to enhance unit volume
Broadened distribution including ex-US licensing and export
Launch of authorized generic (AG) forms
Development of select line extensions including Rx to OTC switches, if possible
Allegiance will synergistically leverage Castleford Capital’s portfolio companies to develop new product opportunities and enhance operational efficiencies.
Team (3)
Sectors Allegiance Bioscience serves:
Health Care
Consumer Services
Join Axial's Private M&A Platform
Allegiance Bioscience connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
